| 1 |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859): 2095-2128.
|
| 2 |
GOLD Committee. Global strategy for the diagnosis, management and prevention of COPD. Global initiative for chronic obstructive lung disease (GOLD)．Update 2011.
URL
|
| 3 |
Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease[J]. Thorax, 1999, 54(7): 581-586.
|
| 4 |
Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test[J]. Eur Respir J, 2009, 34(3): 648-654.
|
| 5 |
van der MT, Willemse BWM, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire[J]. Health Qual Life Outcomes, 2003, 1: 13.
|
| 6 |
Jones PW, Quirk FH, Baveystock CM. The St George' s Respiratory Questionnaire[J]. Respir Med, 1991, 85(Suppl B): 25-31.
|
| 7 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)(二)[J]. 全科医学临床与教育，2013, 11(6): 603-607.
|
| 8 |
陈亚红. 2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J/CD]. 中国医学前沿杂志(电子版), 2017, 9(12): 15-22.
|
| 9 |
Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency[J]. Lancet，2005, 365(9478): 2225-2236.
|
| 10 |
McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction[J]. Am J Respir Crit Care Med, 2001, 164(8 Pt 1): 1419-1424.
|
| 11 |
Singh Dave, Agusti Alvar, Anzueto Antonio, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019[J]. Eur Respir J, 2019, 53(5): 1900164.
|
| 12 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 13 |
马千里，张 巧，廖秀清，等. 重庆地区呼吸专科医师对2011年版GOLD中"COPD综合评估体系"的认知情况和临床应用调查[J]. 中国呼吸与危重监护杂志，2013, 12(4): 325-328.
|
| 14 |
Kocks JWH, Blom CMG, Kasteleyn MJ, et al. Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study[J]. NPJ Prim Care Respir Med, 2017, 27(1): 20.
|
| 15 |
周钰焱，金志贤，刘 翱，等. 慢阻肺患者临床症状评估方法比较及进展[J]. 临床肺科杂志，2019, 24(12): 2284-2287, 2294.
|
| 16 |
张 庆，徐爱晖. CAT评分与mMRC评分对慢性阻塞性肺疾病患者病情评估比较[J]. 临床肺科杂志，2018, 23(12): 2156-2159.
|
| 17 |
杜晓秋. 不同评分系统在慢性阻塞性肺疾病患者中的临床应用[D]. 苏州大学，2015.
|
| 18 |
赵 冲. CAT、mMRC、CCQ、SGRQ四种评分系统在COPD患者肺功能及生活质量评价中的价值与差异[J]. 临床肺科杂志，2018, 23(11): 2060-2064.
|
| 19 |
Ringbaek T, Martinez G, Lange P. A Comparison of the Assessment of Quality of Life with CAT, CCQ, and SGRQ in COPD Patients Participating in Pulmonary Rehabilitation[J]. COPD, 2012, 9(1): 12-15.
|
| 20 |
Tsiligianni IG, Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test(CAT)and the clinical COPD questionnaire(CCQ)[J]. BMC Pulm Med, 2012, 12: 20.
|